The bathroom trips you stopped counting

URINARY CHANGES

6 min read

You assumed you were drinking too much water. Or not enough. You have been adjusting, counting glasses, timing trips. The change was never about the water. The tissue that lines the urethra and supports the bladder is estrogen-sensitive. When estrogen declines during the menopausal transition, that tissue changes, and the urinary symptoms that follow have a clinical name most women have never heard.

This is not about your water intake or your bladder habits. The tissue that supports urinary control changed, and the change is measurable. You are not losing a skill. You are managing a body that shifted underneath you.

The cluster of urinary and genital symptoms that follows estrogen decline has a clinical name most women have never heard: genitourinary syndrome of menopause, or GSM. It was introduced in 2014 by the Menopause Society and the International Society for the Study of Women’s Sexual Health to replace narrower terms that missed the urinary component entirely.

The urinary symptoms include urgency, frequency, nocturia, recurrent urinary tract infections, and both stress and urge incontinence. Before menopause, stress incontinence (leaking with a cough, sneeze, or laugh) is more common. After menopause, urgency incontinence and mixed types dominate. The shift in type reflects the tissue changes underneath.

In the VIVA survey of postmenopausal women, nearly half reported vaginal or urinary symptoms. Only 4 percent attributed them to menopause. Half assumed the symptoms were a normal part of aging. Only 9 percent received a formal diagnosis. The condition is chronic, progressive, and treatable, yet most women experiencing it have never been told the name.

WHAT IT DOES NOT ESTABLISH

Whether urinary changes in any individual are entirely attributable to estrogen decline. Aging, parity, body weight, prior pelvic surgery, and medications all contribute independently. GSM is one pattern that fits, and the tissue changes are real, but a clinical evaluation is needed to determine what is driving symptoms in each person.

ESTROGEN RECEPTORS IN THE LOWER URINARY TRACT

Estrogen receptors are present in the urethra, bladder trigone, and pelvic floor muscles. Estrogen maintains blood flow, tissue thickness, elasticity, and collagen content in these structures. When levels decline, the urethral lining thins, the mucosa loses its seal, and supporting structures weaken. Urethral closure pressure drops, and sensitivity to bladder filling increases.

THE NUMBERS

50–70%

Of postmenopausal women symptomatic with genitourinary syndrome of menopause to at least some degree. The condition is chronic and progressive. StatPearls, 2024.

Of women with vaginal or urinary symptoms who attributed them to menopause (VIVA survey). Half assumed the changes were a normal consequence of aging. Only 9 percent received a formal diagnosis.

The gap between those two figures is the story. A majority of postmenopausal women experience these symptoms. Almost none of them are told why. The condition has a name, a mechanism, and treatments with evidence behind them. The silence around it is the failure, not the body.

THE INTERVENTION WITH THE STRONGEST EVIDENCE

Pelvic floor muscle training

META-ANALYSIS, 92% IMPROVEMENT RATE

A 2025 meta-analysis of studies in postmenopausal women found a 92 percent probability of significant improvement in urinary incontinence symptoms with pelvic floor muscle training compared with controls. Of 15 studies analyzed in a separate systematic review, 14 showed improvement in pelvic floor function.

A 2023 systematic review also found that vaginal estrogen improves dysuria, frequency, urgency, and both stress and urge incontinence in postmenopausal women. This is a prescription treatment and a separate conversation with your doctor.

“This guideline covers the evaluation and treatment of women who present to a clinician with symptoms and signs of genitourinary syndrome of menopause.”

AMERICAN UROLOGICAL ASSOCIATION, AUA/SUFU/AUGS GUIDELINE, 2025

WHAT IT IS NOT

Pelvic floor training does not restore estrogen or reverse the tissue changes of GSM. It strengthens the muscles that support urinary control. For women with moderate to severe symptoms, the AUA guideline recommends evaluation for additional treatments including vaginal estrogen, which addresses the tissue directly.

WHEN TO CALL

Blood in the urine, even once. This requires evaluation to rule out causes beyond GSM regardless of other symptoms.

Burning or pain with urination that does not resolve, or three or more urinary tract infections in a year. Recurrent UTIs in postmenopausal women may be related to GSM and can be treated with vaginal estrogen.

Urinary incontinence that is affecting your daily life, sleep, or activity. This is treatable. The first step is a conversation with your doctor or a referral to a urogynecologist.

THIS WEEK

Identify the pelvic floor muscles: they are the muscles you would use to stop the flow of urine midstream. Do not practice by actually stopping urine flow. Just identify the sensation, then use it outside the bathroom.

Contract and hold for 5 seconds. Release for 5 seconds. Repeat 10 times. Do this three times a day. You can do it sitting at your desk, standing in line, or lying in bed. No one can tell.

If urgency, frequency, or leaking has been present for more than a few weeks, mention it to your doctor. Say the words genitourinary syndrome of menopause. The 2025 AUA guideline now covers this condition specifically, and treatments are available.

The pelvic floor contraction is invisible, silent, and takes thirty seconds. You can do it right now, reading this sentence. No one will know. The muscles that support urinary control respond to training the same way any muscle does: with repeated use. The starting point is knowing which muscles to contract, and now you do.

ONE TAP, NO FORM

What changed about the bathroom?

Tapping opens a pre-written reply. Nothing is public, nothing goes to a list. What most readers tap decides what gets explained next.

I go more often and cannot always wait

I leak when I cough, sneeze, or laugh

I wake up to go more than once a night

I have not talked to anyone about this

Or write in your own words. Every reply is read.

Read recent issues

EVERY SOURCE READ FOR THIS ISSUE

Seven sources: one UI prevalence systematic review, one narrative review, one clinical guideline, one PFMT meta-analysis, one PFMT systematic review, one hormone therapy systematic review, and one GSM reference entry.

1	The link between menopause and urinary incontinence: a systematic review Systematic review, 11 studies, 8,547 women, 2024

2	Involuntary urine loss in menopause: a narrative review Narrative review, Journal of Clinical Medicine, 2025

3	Genitourinary syndrome of menopause: AUA/SUFU/AUGS guideline Clinical practice guideline, American Urological Association, 2025

4	Effect of pelvic floor muscle training on urinary incontinence symptoms in postmenopausal women Systematic review and meta-analysis, Marcellou et al., European Journal of Obstetrics and Gynecology, 2025

5	Training interventions used in postmenopausal women to improve pelvic floor muscle function Systematic review, 15 studies, 2025

6	Menopause hormone therapy and urinary symptoms: a systematic review Systematic review, Menopause, 2023

7	Genitourinary syndrome of menopause Reference entry, StatPearls, 2024

Read more from The Cortisol Effect